skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
HyperCVAD Regimen (Code C63455)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: HyperCVAD Regimen

Definition: A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule, used to treat adult L3 acute lymphoblastic leukemia (ALL3 or Burkitt's-type) and adult small non-cleaved cell (Burkitt's) lymphoma.

Label: HyperCVAD Regimen

NCI Thesaurus Code: C63455 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1881082  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
HyperCVAD Regimen
Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Regimen

External Source Codes: 
UMLS CUI C1881082

Other Properties:
     Name Value (qualifiers indented underneath)
code C63455
DesignNote Source: NCCN Guidelines 2007
Legacy_Concept_Name Hyper-CVAD_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63455

Mainbox Bottom